Cargando…

Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease in the world. NAFLD is principally characterized by an excessive fat accumulation in the hepatocytes. Diet is considered as one of the main drivers to modulate the composition of gut microbiota, which participate in different...

Descripción completa

Detalles Bibliográficos
Autores principales: Quesada-Vázquez, Sergio, Aragonès, Gerard, Del Bas, Josep M, Escoté, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016763/
https://www.ncbi.nlm.nih.gov/pubmed/31936799
http://dx.doi.org/10.3390/cells9010176
_version_ 1783497050015399936
author Quesada-Vázquez, Sergio
Aragonès, Gerard
Del Bas, Josep M
Escoté, Xavier
author_facet Quesada-Vázquez, Sergio
Aragonès, Gerard
Del Bas, Josep M
Escoté, Xavier
author_sort Quesada-Vázquez, Sergio
collection PubMed
description Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease in the world. NAFLD is principally characterized by an excessive fat accumulation in the hepatocytes. Diet is considered as one of the main drivers to modulate the composition of gut microbiota, which participate in different processes, affecting human metabolism. A disruption in the homeostasis of gut microbiota may lead to dysbiosis, which is commonly reflected by a reduction of the beneficial species and an increment in pathogenic microbiota. Gut and liver are in close relation due to the anatomical and functional interactions led by the portal vein, thus altered intestinal microbiota might affect liver functions, promoting inflammation, insulin resistance and steatosis, which is translated into NAFLD. This review will highlight the association between diet, gut microbiota and liver, and how this axis may promote the development of NAFLD progression, discussing potential mechanisms and alterations due to the dysbiosis of gut microbiota. Finally, it will revise the variations in gut microbiota composition in NAFLD, and it will focus in specific species, which directly affect NAFLD progression.
format Online
Article
Text
id pubmed-7016763
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70167632020-02-28 Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis Quesada-Vázquez, Sergio Aragonès, Gerard Del Bas, Josep M Escoté, Xavier Cells Review Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease in the world. NAFLD is principally characterized by an excessive fat accumulation in the hepatocytes. Diet is considered as one of the main drivers to modulate the composition of gut microbiota, which participate in different processes, affecting human metabolism. A disruption in the homeostasis of gut microbiota may lead to dysbiosis, which is commonly reflected by a reduction of the beneficial species and an increment in pathogenic microbiota. Gut and liver are in close relation due to the anatomical and functional interactions led by the portal vein, thus altered intestinal microbiota might affect liver functions, promoting inflammation, insulin resistance and steatosis, which is translated into NAFLD. This review will highlight the association between diet, gut microbiota and liver, and how this axis may promote the development of NAFLD progression, discussing potential mechanisms and alterations due to the dysbiosis of gut microbiota. Finally, it will revise the variations in gut microbiota composition in NAFLD, and it will focus in specific species, which directly affect NAFLD progression. MDPI 2020-01-10 /pmc/articles/PMC7016763/ /pubmed/31936799 http://dx.doi.org/10.3390/cells9010176 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Quesada-Vázquez, Sergio
Aragonès, Gerard
Del Bas, Josep M
Escoté, Xavier
Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
title Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
title_full Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
title_fullStr Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
title_full_unstemmed Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
title_short Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
title_sort diet, gut microbiota and non-alcoholic fatty liver disease: three parts of the same axis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016763/
https://www.ncbi.nlm.nih.gov/pubmed/31936799
http://dx.doi.org/10.3390/cells9010176
work_keys_str_mv AT quesadavazquezsergio dietgutmicrobiotaandnonalcoholicfattyliverdiseasethreepartsofthesameaxis
AT aragonesgerard dietgutmicrobiotaandnonalcoholicfattyliverdiseasethreepartsofthesameaxis
AT delbasjosepm dietgutmicrobiotaandnonalcoholicfattyliverdiseasethreepartsofthesameaxis
AT escotexavier dietgutmicrobiotaandnonalcoholicfattyliverdiseasethreepartsofthesameaxis